Acknowledgment
Carlos S. Cabalag is the recipient of and supported by The Alan & Kate Gibson Research Fellowship, 2019.
Author information
Authors and Affiliations
Contributions
CSC – Conceptualization, methodology, data curation, formal analysis, investigation, validation, writing – original draft, review & editing. OWJP – Conceptualization, methodology, data curation, writing – review & editing. JC – Methodology, data curation, writing – review & editing. LG - Methodology, data curation, writing – review & editing. NT - Methodology, data curation, software, formal analysis, writing – review & editing. MJ – survival analysis, creation of nomogram, writing – review & editing. TYML - Methodology, data curation, writing – review & editing. JM - Methodology, formal analysis, writing – review & editing. KMF – data curation, formal analysis, writing – review & editing. LC – Project administration, resources, supervision, writing – review & editing. MWH - Project administration, resources, supervision, writing – review & editing. GMA – Methodology, supervision, writing – review & editing. PJN – Conceptualization, resources, supervision, writing – review & editing. NJC – Conceptualization, resources, funding acquisition, supervision, writing – review & editing. WAP - Conceptualization, resources, funding acquisition, supervision, writing – review & editing. CPD - Conceptualization, resources, funding acquisition, supervision, writing – review & editing.
Corresponding authors
Ethics declarations
Disclosure
Paul Neeson received research funding from BMS, Roche Genentech, Allergan, Compugen, MSD, and Crispr Therapeutics. The remaining authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Co-senior authors: Wayne A. Phillips, Cuong P. Duong, Nicholas J. Clemons.
Rights and permissions
About this article
Cite this article
Cabalag, C.S., Prall, O.W.J., Ciciulla, J. et al. ASO Visual Abstract: Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer. Ann Surg Oncol 30, 1628–1629 (2023). https://doi.org/10.1245/s10434-022-12633-7
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12633-7